Project Grant SEI30020GR0012

This $300,000 Project Grant from the National Science Foundation's Office of International Science and Engineering will fund research collaboration between the United States and international partners on modeling human mobility patterns and contagion dynamics during the COVID-19 pandemic. Awarded on August 1, 2021 to The Research Foundation For The State University Of New York (SUNY) at Binghamton, the two-year grant aims to advance scientific discovery and international partnerships through...

This Project Grant award of $503,637 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate the mechanisms leading to thrombotic events and microclot formation in patients with COVID-19 infection. The primary objectives are to longitudinally assess changes in the hemostatic and fibrinolytic systems during acute COVID-19 infection and post-infection, determine the contributions of key regulatory proteins like protein S...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $188,544.00 to The University of Iowa to conduct research aimed at understanding the role of the SAMHD1 protein in regulating SARS-CoV-2 infection and innate immune responses. The key objectives are to examine how SARS-CoV-2 infection impacts SAMHD1 phosphorylation and its effects on inflammation in primary human...

This $2,353,903 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to assess the prevalence, clinical impact, and virus-host dynamics of SARS-CoV-2 and respiratory virus co-infections in children. The primary objectives are to: 1) determine the prevalence of co-infection and its association with clinical outcomes, 2) characterize the mucosal immune response to...

This $19,786,074 Cooperative Agreement award was issued by the National Center for Immunization and Respiratory Diseases (part of the Centers for Disease Control and Prevention) under CFDA 93.354 "Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response". The award will fund a 5-year prospective observational study on respiratory virus epidemiology in the Greater Boston area. Key research activities include: Planning and preparing to...

This $195,101 Project Grant, awarded by the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074), will use mathematical modeling to project the healthcare burden associated with COVID-19, influenza, and respiratory syncytial virus (RSV) in the United States during the 2023-2024 respiratory virus season. The research will integrate estimates of population immunity from prior infections, vaccinations, and monoclonal antibody therapy to produce four rounds of projections...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $814,873 to conduct research on the immunogenetics of the COVID-19 immune response. The key objectives are to: Perform a large genome-wide association study to identify genetic associations with COVID-19 infection and vaccine-induced immune responses, including antibody levels. This includes replicating findings in...

This $250,000 Cooperative Agreement award, issued by the U.S. Department of State's Bureau of European and Eurasian Affairs on October 2, 2024, aims to grow and sustain the modern research administration and development offices of higher education and research institutions in Georgia. The goal is to increase their contribution to innovation and economic growth within the region. The award, funded under the AEECA/ESF Public Diplomacy Programs (CFDA 19.900), will support a range of...

The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...

The National Science Foundation (CFDA 47.074 Biological Sciences) awarded a $1,487,500 Cooperative Agreement to the University of California, Davis to establish the Center for Insights into the Pre-Emergence Phase of Pandemics (CI3P). The center will conduct transdisciplinary research and develop innovative technology to detect early signals of pandemic threats in natural reservoirs and ecosystems. Key activities include: Developing sensor systems to monitor wildlife health and pathogen...